BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34363722)

  • 21. TGF-β-mediated LEFTY/Akt/GSK-3β/Snail axis modulates epithelial-mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas.
    Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Akiya M; Saegusa M
    Mol Carcinog; 2018 Aug; 57(8):957-967. PubMed ID: 29603383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
    Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M
    J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stemness and chemoresistance are imparted to the OC cells through TGFβ1 driven EMT.
    Mitra T; Prasad P; Mukherjee P; Chaudhuri SR; Chatterji U; Roy SS
    J Cell Biochem; 2018 Jul; 119(7):5775-5787. PubMed ID: 29537103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
    Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
    Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
    Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
    Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells.
    Qian XQ; Tang SS; Shen YM; Chen LL; Cheng XD; Wan XY
    Int J Med Sci; 2020; 17(9):1215-1223. PubMed ID: 32547317
    [No Abstract]   [Full Text] [Related]  

  • 27. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hollow spheroids in ascites of ovarian clear cell carcinoma: how are they formed and how do they behave?
    Kato N; Narutomi K; Fukase M; Motoyama T
    Cytopathology; 2012 Apr; 23(2):120-5. PubMed ID: 21306451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
    Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
    Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
    Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
    Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway.
    Yang L; Yang M; Cui C; Long X; Li Y; Dai W; Lang T; Zhou Q
    Cell Signal; 2023 Jul; 107():110688. PubMed ID: 37105506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
    Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
    J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.
    Dong Z; Yang L; Lai D
    Cell Prolif; 2013 Aug; 46(4):425-35. PubMed ID: 23869764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
    Latifi A; Abubaker K; Castrechini N; Ward AC; Liongue C; Dobill F; Kumar J; Thompson EW; Quinn MA; Findlay JK; Ahmed N
    J Cell Biochem; 2011 Oct; 112(10):2850-64. PubMed ID: 21618587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain.
    Kang HG; Kim DH; Kim SJ; Cho Y; Jung J; Jang W; Chun KH
    Oncotarget; 2016 Oct; 7(42):68229-68241. PubMed ID: 27626163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
    Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
    Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.